Medtronic’s country director for Saudi Arabia, Mohammed El Ansari, comments on the implications of the company’s decision to move to a direct presence in the Kingdom, positioning the affiliate as a career launchpad for local talent, the local manufacturing of ventilators, and why Medtronic considers Saudi Arabia a priority market.
Saudi Arabia is a key market for Medtronic, especially in the region, given the high level of technology adoption, innovation, and heavy investment in healthcare
IQVIA Vice President and General Manager Saudi Arabia & Egypt Mohamed Mostafa gives his expert insights into the transformation of the Saudi pharma market in recent years, covering everything from…
Mecomed is the largest medical devices, imaging, and diagnostics trade association in the Middle East and Africa (MEA). Rami Rajab, chairman, highlights the role of the association in shaping the…
Mohamed Mazen Batterjee, managing director of Batterjee Pharma, explains how he has turned the business around since joining in 2014, the interplay between the firm’s contract and proprietary manufacturing operations,…
Saudi Chemical Company Holding (SCCH), Saudi Arabia’s leading manufacturer of civil and military explosives, has been expanding its pharma sector footprint in recent years. Today, the company has capabilities across…
Seasoned executive Mohamed Nasser currently oversees 16 markets for Amgen across the MEA region, including its most important – Saudi Arabia. He shares some of the key skills that pharma…
While Saudi Arabia is becoming an increasingly attractive investment destination for global pharma, some stakeholders continue to have concerns about whether the country’s intellectual property (IP) protection system is truly…
See our Cookie Privacy Policy Here